Insider · CIK 0002120762
Benjamin Lane
Files at NUVL (Nuvalent, Inc.). First filing -, latest -.
In brief
Benjamin Lane files SEC Form 4 as officer at NUVL (Nuvalent, Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Benjamin Lane has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 13 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jul 15, 2026 | NUVL Nuvalent, Inc. | UTender of shares Class A Common Stock | -21,092 | $124.00 | $2.6M | 0 | Jul 15, 2026 |
| Jul 15, 2026 | NUVL Nuvalent, Inc. | DDisposition to issuer Class A Common Stock - Restricted Stock Units | -29,433 | - | - | 0 | Jul 15, 2026 |
| Jul 15, 2026 | NUVL Nuvalent, Inc. | AGrant or award Class A Common Stock - Performance Stock Units | +7,120 | $0.00 | $0 | 7,120 | Jul 15, 2026 |
| Jul 15, 2026 | NUVL Nuvalent, Inc. | DDisposition to issuer Class A Common Stock - Performance Stock Units | -7,120 | - | - | 0 | Jul 15, 2026 |
| Jul 15, 2026 | NUVL Nuvalent, Inc. | DDisposition to issuer Stock Option (Right to Buy)derivative | -731 | - | - | 0 | Jul 15, 2026 |
| Jul 15, 2026 | NUVL Nuvalent, Inc. | DDisposition to issuer Stock Option (Right to Buy)derivative | -8,333 | - | - | 0 | Jul 15, 2026 |
| Jul 15, 2026 | NUVL Nuvalent, Inc. | DDisposition to issuer Stock Option (Right to Buy)derivative | -17,848 | - | - | 0 | Jul 15, 2026 |
| Jul 15, 2026 | NUVL Nuvalent, Inc. | DDisposition to issuer Stock Option (Right to Buy)derivative | -15,052 | - | - | 0 | Jul 15, 2026 |
| Jul 15, 2026 | NUVL Nuvalent, Inc. | DDisposition to issuer Stock Option (Right to Buy)derivative | -12,025 | - | - | 0 | Jul 15, 2026 |
| Jul 15, 2026 | NUVL Nuvalent, Inc. | DDisposition to issuer Stock Option (Right to Buy)derivative | -8,000 | - | - | 0 | Jul 15, 2026 |
| Jul 15, 2026 | NUVL Nuvalent, Inc. | DDisposition to issuer Stock Option (Right to Buy)derivative | -19,000 | - | - | 0 | Jul 15, 2026 |
| Apr 1, 2026 | NUVL Nuvalent, Inc. | AGrant or award Class A Common Stock | +9,500 | $0.00 | $0 | 50,368 | Apr 2, 2026 |
| Apr 1, 2026 | NUVL Nuvalent, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +19,000 | $0.00 | $0 | 19,000 | Apr 2, 2026 |
Questions about Benjamin Lane
Answered from the filings on this page, as of the latest one.
Is Benjamin Lane buying or selling?
Benjamin Lane has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Benjamin Lane's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Benjamin Lane has 0.
Where does Benjamin Lane file Form 4?
Benjamin Lane has filed Form 4 at NUVL (Nuvalent, Inc.) as See Remarks. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.